Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, September 8, 2025.
Cellectar Biosciences, Inc. (NASDAQ:CLRB)
Strong Uptrend (+100) - CLRB is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, CLRB continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid CLRB?
MarketClub looks at technical strength and momentum to determine if the timing is right for CLRB.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CLRB
The long-term trend has been UP since Jun 4th, 2025 at 0.4053
The intermediate-term trend has been UP since Aug 27th, 2025 at 5.0900
The short-term trend has been UP since Sep 3rd, 2025 at 5.0000
Smart Scan Analysis for CLRB
Based on our trend formula, CLRB is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 4.9400 | 5.1899 | 4.8500 | 5.0500 | +0.0700 |
| Prev. Close | Volume | Bid | Ask | Time |
| 4.9800 | 83356 | 2025-09-08 15:58:26 |
| Year High | 14.4 | Year High Date | 2018-01-02 |
| Year Low | 2.02 | Year Low Date | 2018-11-21 |
| 52wk High | 67.5 | 52wk High Date | 2024-10-04 |
| 52wk Low | 4.11 | 52wk Low Date | 2025-08-20 |
| Average Volume | 154,765 | Shares Outstanding | 3,192 |
| Market Cap | 22M | Assets | 13,695,183M |
| Liabilities | 6,228,148M | P/E Ratio | -1.24810000 |
| Volatility | 60.8 |